NCT06621758 · UNKNOWN

Communication Regarding Preclinical Dementia Diagnostic and Diagnostic Disclosure Among Patients with MCI and SCD

Sponsor: Danish Dementia Research Centre

This study uses questionnaires to learn what people with mild cognitive impairment or subjective cognitive decline want to know during diagnostic counseling — and how they want that information delivered. It is not testing a drug or treatment. The phase is unspecified, which typically means this is observational research, not a clinical intervention trial.

Eligibility criteria

Inclusion Criteria:
* Diagnosed with SCD or MCI
* Lumbar puncture performed during the diagnostic process
* Age at or below 80 years
* MMSE at or above 24
Exclusion Criteria:
* Diagnosis of current major psychiatric disorder (schizophrenia, bipolar disorder, psychosis)
* Current excessive alcohol intake or substance abuse
Inclusion criteria for the co-participant:
* Attended the diagnostic disclosure visit together with the individual diagnosed with SCD or MCI

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2024-10-01

View full record on ClinicalTrials.gov

All APOE4 clinical trials